GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial results for its anthrax vaccine 'BARYTHRAX inj. (GC1109)' have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback